• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGELINI THERMACARE LOWER BACK AND HIP 8CT + NSW 1CT; HOT OR COLD DISPOSABLE PACK.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGELINI THERMACARE LOWER BACK AND HIP 8CT + NSW 1CT; HOT OR COLD DISPOSABLE PACK. Back to Search Results
Lot Number GA00155
Device Problem Insufficient Information (3190)
Patient Problems Erythema (1840); Hemorrhage/Bleeding (1888); Pain (1994); Peeling (1999); Skin Tears (2516); Partial thickness (Second Degree) Burn (2694)
Event Date 10/30/2022
Event Type  Injury  
Manufacturer Narrative
The root cause cannot be identified.There was limited device-specific information provided, no batch number or return sample available for evaluation.Without a batch reference number, a manufacturing and technical assessment cannot be completed for the wrap involved in this case.No product quality-related trend was identified for the subclass adverse event safety request for investigation.Care should be taken when using the device, following all safety and use information as provided with the wrap to avoid the risk of burns.The manufacturing operations employ quality control procedures, including process testing, thermal testing, and visual inspection, to ensure the quality of the packaged product.
 
Event Description
On 31-oct-2022, a spontaneous report from the united states was received via email regarding a 68-year-old female consumer who used thermacare lower back & hip 8hr.Medical history included hypertension, seasonal allergies, and drug allergies to cefzil (cefprozil) and "sulfa" sulfonamides.The consumer reported that she had been using thermacare heat wraps for an unspecified number of years and loved them.Concomitant products included losartan, metoprolol, and other unspecified medications that the consumer declined to provide.On (b)(6) 2022, she applied a thermacare lower back & hip 8ct l/xl to her low back/hip area directly on her skin even though the label indicates to use a clothing barrier if above the age of 55.She noted she was recently burned.It was clarified that she left the heat wrap on for approximately nine to ten hours despite label instructions not to use longer than eight hours in a 24-hour period.When she later removed the wrap, she stated that the skin came off with the wrap which prompted her to look at the area.She noticed redness and skin peeling which she assumed was a deroofed blister.She reported that the area was painful and bled for a short amount of time.At the time of reporting, all symptoms are ongoing except for the bleeding.The consumer reported that no medical care had been sought and that she had been applying neosporin to the affected area.She denied the presence any signs or symptoms of infection.On 03-nov-2022 during a follow-up telephone call to the consumer, she noted that the pain had abated and that although there was some mild redness and peeling of the skin still present, the area was healing was healing.Consumer stated that she had not been evaluated by a medical provider as recommended.No further information was received after 03-nov-2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE LOWER BACK AND HIP 8CT + NSW 1CT
Type of Device
HOT OR COLD DISPOSABLE PACK.
Manufacturer (Section D)
ANGELINI
1231 wyandotte dr
albany GA 31705
Manufacturer (Section G)
BRIDGES CONSUMER HEALTHCARE
811 broad street, suite 600
chattanooga TN 37402
Manufacturer Contact
scott hughes
811 broad street, suite 600
chattanooga, TN 37402
4234142221
MDR Report Key15858566
MDR Text Key304279596
Report Number3007593958-2022-00078
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/23/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/30/2024
Device Lot NumberGA00155
Date Manufacturer Received10/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LOSARTAN.; METOPROLOL.; UNSPECIFIED MEDICATIONS.
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexFemale
-
-